240 related articles for article (PubMed ID: 20054104)
41. In Silico Design and Immunologic Evaluation of HIV-1 p24-Nef Fusion Protein to Approach a Therapeutic Vaccine Candidate.
Larijani MS; Sadat SM; Bolhassani A; Pouriayevali MH; Bahramali G; Ramezani A
Curr HIV Res; 2018; 16(5):322-337. PubMed ID: 30605062
[TBL] [Abstract][Full Text] [Related]
42. Co-delivery of LIGHT expression plasmid enhances humoral and cellular immune responses to HIV-1 Nef in mice.
Wen J; Hao W; Fan Y; Du J; Du B; Qian M; Jiang W
Arch Virol; 2014 Jul; 159(7):1663-9. PubMed ID: 24435162
[TBL] [Abstract][Full Text] [Related]
43. [Immunological efficiency induced by HIV-1 p24 DNA combined with P24 protein].
Wang Q; Chen Y; Gao S; Jiang W; Song L; Huang W
Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):773-80. PubMed ID: 21845844
[TBL] [Abstract][Full Text] [Related]
44. [Construction of Helicobacter pylori Lpp20-IL2 DNA vaccine and evaluation of its immunocompetence in C57BL/6 mice].
Yu W; Zhang Y; Jing J; Liu Z
Wei Sheng Wu Xue Bao; 2010 Apr; 50(4):554-9. PubMed ID: 20560362
[TBL] [Abstract][Full Text] [Related]
45. Small heat shock protein 27: An effective adjuvant for enhancement of HIV-1 Nef antigen-specific immunity.
Milani A; Bolhassani A; Shahbazi S; Motevalli F; Sadat SM; Soleymani S
Immunol Lett; 2017 Nov; 191():16-22. PubMed ID: 28917624
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine.
Sadat Larijani M; Ramezani A; Mashhadi Abolghasem Shirazi M; Bolhassani A; Pouriayevali MH; Shahbazi S; Sadat SM
Virus Res; 2021 Jun; 298():198403. PubMed ID: 33775753
[TBL] [Abstract][Full Text] [Related]
47. Immunomodulation of bivalent Newcastle disease DNA vaccine induced immune response by co-delivery of chicken IFN-γ and IL-4 genes.
Sawant PM; Verma PC; Subudhi PK; Chaturvedi U; Singh M; Kumar R; Tiwari AK
Vet Immunol Immunopathol; 2011 Nov; 144(1-2):36-44. PubMed ID: 21820185
[TBL] [Abstract][Full Text] [Related]
48. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
[TBL] [Abstract][Full Text] [Related]
49. Construction of a recombinant plasmid harbouring the glyceraldenyde-3-phosphate dehydrogenase gene of periodic Brugia malayi and observation on DNA immunity.
Fang Z; Tong H; Zhang S; Fang H; Lu S; Xu B
Indian J Med Microbiol; 2012; 30(2):193-7. PubMed ID: 22664436
[TBL] [Abstract][Full Text] [Related]
50. HIV-1 Nef impairs multiple T-cell functions in antigen-specific immune response in mice.
Fujii H; Ato M; Takahashi Y; Otake K; Hashimoto S; Kaji T; Tsunetsugu-Yokota Y; Fujita M; Adachi A; Nakayama T; Taniguchi M; Koyasu S; Takemori T
Int Immunol; 2011 Jul; 23(7):433-41. PubMed ID: 21642447
[TBL] [Abstract][Full Text] [Related]
51. Improving the potency of DNA vaccine encoding HIV-1 Nef antigen using two endogenous adjuvants in mouse model.
Jafarzade BS; Sadat SM; Yaghobi R; Bolhassani A
Bratisl Lek Listy; 2017; 118(9):564-569. PubMed ID: 29061065
[TBL] [Abstract][Full Text] [Related]
52. Co-utilization of a TLR5 agonist and nano-formulation of HIV-1 vaccine candidate leads to increased vaccine immunogenicity and decreased immunogenic dose: A preliminary study.
Rostami H; Ebtekar M; Ardestani MS; Yazdi MH; Mahdavi M
Immunol Lett; 2017 Jul; 187():19-26. PubMed ID: 28479111
[TBL] [Abstract][Full Text] [Related]
53. The extradomain A of fibronectin (EDA) combined with poly(I:C) enhances the immune response to HIV-1 p24 protein and the protection against recombinant Listeria monocytogenes-Gag infection in the mouse model.
San Román B; De Andrés X; Muñoz PM; Obregón P; Asensio AC; Garrido V; Mansilla C; Arribillaga L; Lasarte JJ; De Andrés D; Amorena B; Grilló MJ
Vaccine; 2012 Mar; 30(15):2564-9. PubMed ID: 22326778
[TBL] [Abstract][Full Text] [Related]
54. Induction of broad-based immune response against HIV-1 subtype C gag DNA vaccine in mice.
Chugh P; Seth P
Viral Immunol; 2004; 17(3):423-35. PubMed ID: 15357908
[TBL] [Abstract][Full Text] [Related]
55. Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination.
Castaldello A; Sgarbanti M; Marsili G; Brocca-Cofano E; Remoli AL; Caputo A; Battistini A
J Cell Physiol; 2010 Sep; 224(3):702-9. PubMed ID: 20432465
[TBL] [Abstract][Full Text] [Related]
56. [Immunogenicities and comparison of DNA vaccines encoding pol genes derived from B`/C and A/E recombinant HIV-1 strains].
Wan YM; Ren YQ; Wang J; Ren XN; Hu ZD; Qiu C; Xu JQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jun; 46(6):551-5. PubMed ID: 22943905
[TBL] [Abstract][Full Text] [Related]
57. Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine.
Kim BJ; Kim BR; Kook YH; Kim BJ
Front Immunol; 2018; 9():643. PubMed ID: 29636755
[TBL] [Abstract][Full Text] [Related]
58. In vivo delivery of a multiepitope peptide and Nef protein using novel cell-penetrating peptides for development of HIV-1 vaccine candidate.
Davoodi S; Bolhassani A; Namazi F
Biotechnol Lett; 2021 Mar; 43(3):547-559. PubMed ID: 33386500
[TBL] [Abstract][Full Text] [Related]
59. Immunogenicity analysis following human immunodeficiency virus recombinant DNA and recombinant vaccinia virus Tian Tan prime-boost immunization.
Liu C; Du S; Li C; Wang Y; Wang M; Li Y; Yin R; Li X; Ren D; Qin Y; Ren J; Jin N
Sci China Life Sci; 2013 Jun; 56(6):531-40. PubMed ID: 23645103
[TBL] [Abstract][Full Text] [Related]
60. Introducing a frameshift mutation to the POL sequence of HIV-1 provirus and evaluation of the immunogenic characteristics of the mutated virions (RINNL4-3).
Zabihollahi R; Sadat SM; Vahabpour R; Salehi M; Azadmanesh K; Siadat SD; Saraji AR; Pouriavali MH; Momen SB; Aghasadeghi MR
Mol Biol (Mosk); 2012; 46(3):519-24. PubMed ID: 22888641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]